Diabetes Obes Metab 19(4):524536 Husain M, Bain SC, Holst AG, Mark T, Rasmussen S, Lingvay I (2020) Effects of semaglutide on risk of cardiovascular events across a continuum of cardiovascular risk: combined post hoc analysis of the SUSTAIN and PIONEER trials
JAMA 327 , 534545 (2022)
Some of these drugs are now also approved to reduce the risk of heart attacks , strokes, and heart-related deaths in certain populations
The opposite pattern, losing limb circumference while waist remains stable, suggests muscle loss that requires intervention
For instance, the changes in hormonal expression in EC cells
Her biggest concern for people with diabetes and supplements is the risk of hypoglycemia , since many supplements claim to improve or lower blood sugar